title: Dose of Methylphenidate during Service Transition for Adults with ADHD.
abstract: OBJECTIVE
  We wanted to investigate how one element of the transitional process of adolescents to an adult ADHD service, namely the use of medication, fared when compared to the recommendations of national guidelines.
  
  
  METHODS
  We did a chart review of the dose of stimulants in a cohort of transitional patients after they were transferred to an adult ADHD service, whilst investigating if other variables such as severity of ADHD, age, gender and comorbidity played any role in determining the dose of stimulants at transition.
  
  
  RESULTS
  The dose of stimulants when calculated in mg/kg was almost half the recommended whist the patients were also severely symptomatic. Reported comorbidity with Autistic Spectrum Disorders was also very high.
  
  
  CONCLUSIONS
  A handover approach of adolescents with ADHD to an adult service, may hide gaps at least as far as prescribing is concerned. This gap may need considerable resources to address successfully. We suggest that establishing transitional processes may help minimise this problem.
authors: Leeds Partnerships NHS Foundation Trust, Leeds, UK.
authors: Marios
authors: M
authors: Adamou
authors: Sara
authors: S
authors: Bowers
keywords: Adult ADHD; Methylphenidate; Service Transition
references: Child Care Health Dev. 2008 Sep;34(5):564-6
references: 18796048
references: Child Adolesc Ment Health. 2002 May;7(2):73-78
references: 33158342
references: BMC Fam Pract. 2002 Apr 16;3:7
references: 11955289
references: Am J Psychiatry. 2005 Sep;162(9):1621-7
references: 16135620
references: Curr Opin Psychiatry. 2009 Jul;22(4):386-90
references: 19417667
references: J Am Acad Child Adolesc Psychiatry. 2003 Oct;42(10):1203-11
references: 14560170
references: Clin Child Psychol Psychiatry. 2008 Apr;13(2):287-304
references: 18540230
references: Clin Pediatr (Phila). 1999 Apr;38(4):209-17
references: 10326176
references: J Psychopharmacol. 2007 Jan;21(1):10-41
references: 17092962
references: J Clin Psychopharmacol. 2010 Oct;30(5):549-53
references: 20814332
references: Compr Psychiatry. 1990 Sep-Oct;31(5):416-25
references: 2225800
references: J Am Acad Child Adolesc Psychiatry. 2000 Feb;39(2):198-206
references: 10673831
references: BMC Health Serv Res. 2008 Jun 23;8:135
references: 18573214
references: J Atten Disord. 2005 Nov;9(2):384-91
references: 16371661
references: Ment Retard Dev Disabil Res Rev. 2002;8(3):162-70
references: 12216060
references: BMJ. 1998 May 23;316(7144):1594-6
references: 9596603
references: Am J Psychiatry. 2006 Apr;163(4):716-23
references: 16585449
references: Am J Psychiatry. 1993 Dec;150(12):1792-8
references: 8238632